Rhabdomyolysis during concomitant ticagrelor and rosuvastatin: A breast cancer resistance protein-mediated drug interaction?

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalBritish Journal of Clinical Pharmacology
Volume89
Issue number7
Pages (from-to)2309-2315
Number of pages7
ISSN0306-5251
DOIs
Publication statusPublished - Jul 2023
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Drug-drug-interaction
  • Myotoxicity
  • Rhabdomyolysis
  • Rosuvastatin
  • Ticagrelor
  • 317 Pharmacy

Cite this